TRIM31 and glaucoma: β2-agAAb seropositive patients showed no correlation of β2-agAAb beat rate with MD (p>0.05), RNF thickness (p>0.05), BMO-MRW (p>0.05), RGC thickness (p>0.05) and INL thickness (p>0.05) for group (total cohort) and subgroup (glaucoma suspects, OAG) analysis, respectively (Fig 4).